Abstract:Objective— Thioredoxin-2 (Trx2), a major antioxidant protein in mitochondria, enhances nitric oxide bioavailability and inhibits ASK1-dependent apoptosis in endothelial cells (ECs). However, the in vivo role of Trx2 in angiogenesis has not been defined. Here we used EC-specific transgenesis of Trx2 (Trx2-TG) in mice to determine the in vivo function of Trx2 in arteriogenesis and angiogenesis. Methods and Results— In a femoral artery ligation model, Trx2-TG mice had enhanced capacity in limb perfusion recovery and ischemic reserve capacity compared to the nontransgenic littermates. Ischemia-initiated arteriogenesis in the upper limb was augmented in Trx2-TG mice. Trx2-TG mice also showed significantly enhanced capillary formation and maturation in the lower limb. In nontransgenic limb, ischemia specifically induced a downregulation of Trx2 protein, leading to increased oxidative stress, ASK1 activation, and EC apoptosis. In contrast, Trx2-TG maintained a constitutive level of Trx2, reducing the ischemia-induced deleterious responses. We then defined the mechanism by which Trx2 increases angiogenesis using ECs isolated from Trx2-TG mice. Trx2-TG ECs showed increased NO and NO-dependent migration. In addition, these cells were more resistant to oxidative stress–induced activation of ASK1 signaling and apoptosis. Moreover, Trx2-augmented EC survival is NO-independent. To define the relative contributions of Trx2-increased NO and Trx2-reduced ASK1 apoptotic activity to angiogenesis in vivo, we examined Trx2 effects on ischemia-induced angiogenesis in eNOS-deficient mice. The eNOS deletion caused severe impairment in the functional flow recovery in response to ischemia. Trx2 expression in eNOS-KO mice still dramatically inhibited ischemia-induced ASK1 and EC apoptosis, leading to an enhanced functional flow recovery. Conclusion— These in vivo and in vitro data support that Trx2 maintains EC function by two parallel pathways—scavenging ROS to increase NO bioavailability and inhibiting ASK1 activity to enhance EC survival, facilitating ischemia-mediated arteriogenesis and angiogenesis.

Mechanistic Role of Thioredoxin 2 in Heart Failure.

Endothelial-specific Expression of Mitochondrial Thioredoxin Improves Endothelial Cell Function and Reduces Atherosclerotic Lesions.

Endothelial-Specific Expression of Mitochondrial Thioredoxin Promotes Ischemia-Mediated Arteriogenesis and Angiogenesis

Thioredoxin 2 Offers Protection Against Mitochondrial Oxidative Stress in H9c2 Cells and Against Myocardial Hypertrophy Induced by Hyperglycemia

Thioredoxin-2 Protects Against Oxygen-Glucose Deprivation/reperfusion Injury by Inhibiting Autophagy and Apoptosis in H9c2 Cardiomyocytes.

Abstract 17258: Mitochondrial Redox Protein Thioredoxin 2 is Essential for Preserving Cardiac Function

Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases

Overexpression of Thioredoxin-1 in Transgenic Mice Attenuates Adriamycin-Induced Cardiotoxicity.

Dynamin-2 Mediates Heart Failure By Modulating Ca2+-Dependent Cardiomyocyte Apoptosis

Role of Thioredoxin-1 and its inducers in human health and diseases

Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress.

Dynamic Expression of Thioredoxin 2 in Myocardial Mitochondria in Selenium-Deficiency Rats During Myocardial Injury

Mitochondrial thioredoxin-2 maintains HCN4 expression and prevents oxidative stress-mediated sick sinus syndrome.

Myocardial Ischemia Injury and Thioredoxin System

The structure of thioredoxin and its role in the biological resistance of oxidation stress

Thioredoxin Reductase 2 Synergizes with Cytochrome c, Somatic to Alleviate Doxorubicin-Induced Oxidative Stress in Cardiomyocytes and Mouse Myocardium

Thioredoxin Signaling Pathways in Cancer

The Functions of Thioredoxin 1 in Neurodegeneration

Cardioprotective Effects Of Thioredoxin In Myocardial Ischemia And The Reperfusion Role Of S-Nitrosation

Mitofusin-2 is a Major Determinant of Oxidative Stress-mediated Heart Muscle Cell Apoptosis

Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors